HemaCore is a medtech company, developing medical devices and methods for hemostasis diagnostics.
HemaCore is a medtech company, developing medical devices and methods for hemostasis diagnostics. HemaCore was founded
by a group of scientists from Moscow State University who invented and patented Thrombodynamics – a new global
assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis. Thrombodynamics analyser enables to
evaluate different phases of blood coagulation and diagnose the increased (leading to thromboses, heart attacks and strokes),
decreased (hemorrhages and hemophilia) and combined (DIC-syndrome, sepsis) forms of the blood coagulation disorders.
HemaCore has completed final design of product, started serial production of instruments and disposables.
Sales in Russia for the IVD purposes started in Nov 2012. In Europe Thrombodynamics analyser is sold since Jan 2014, as a RUO device.